We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$1.92B
AUM Growth
+$32.9M
Cap. Flow
-$16.3M
Cap. Flow %
-0.85%
Top 10 Hldgs %
8.38%
Holding
1,808
New
515
Increased
353
Reduced
371
Closed
534

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$17.3M
2
AGN
Allergan plc
AGN
+$13.2M
3
HPQ icon
HP
HPQ
+$10.3M
4
FFIV icon
F5
FFIV
+$9.99M
5
ULTA icon
Ulta Beauty
ULTA
+$9.55M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$18.5M
2
DTV
DIRECTV COM STK (DE)
DTV
+$13.6M
3
INTC icon
Intel
INTC
+$11.7M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.4M
5
AMZN icon
Amazon
AMZN
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 14.72%
2 Consumer Discretionary 12.02%
3 Healthcare 11.61%
4 Industrials 10.37%
5 Energy 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWC
1
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$20.9M 1.09%
141,915
-7,590
-5% -$1.07M
MU icon
2
Micron Technology
MU
$1.12T
$20.2M 1.05%
613,955
+158,350
+35% +$4.32M
CAH icon
3
Cardinal Health
CAH
$52.9B
$19.7M 1.02%
286,646
+46,500
+19% +$3.17M
QCOR
4
DELISTED
QUESTCOR PHARMA INC
QCOR
$18.7M 0.97%
+202,374
New +$17.3M
AMGN icon
5
Amgen
AMGN
$201B
$18M 0.94%
152,286
+59,995
+65% +$6.94M
AGN
6
DELISTED
Allergan plc
AGN
$14.3M 0.74%
+63,923
New +$13.2M
VTR icon
7
Ventas
VTR
$47.6B
$14M 0.73%
191,879
+99,624
+108% +$7.4M
FTI icon
8
TechnipFMC
FTI
$30.3B
$11.8M 0.62%
260,091
+28,325
+12% +$1.2M
APC
9
DELISTED
Anadarko Petroleum
APC
$11.7M 0.61%
106,937
-82,540
-44% -$8.4M
ULTA icon
10
Ulta Beauty
ULTA
$20.5B
$11.5M 0.6%
125,717
+106,150
+542% +$9.55M
ADBE icon
11
Adobe
ADBE
$84.3B
$11.4M 0.59%
157,218
+65,590
+72% +$4.23M
MDLZ icon
12
Mondelez International
MDLZ
$77.1B
$11.3M 0.59%
301,152
+197,710
+191% +$7.23M
HPQ icon
13
HP
HPQ
$22.4B
$10.5M 0.54%
+683,428
New +$10.3M
FFIV icon
14
F5
FFIV
$21.9B
$10.3M 0.54%
+92,845
New +$9.99M
BKNG icon
15
Booking.com
BKNG
$134B
$10.2M 0.53%
210,950
+53,775
+34% +$2.58M
VLO icon
16
Valero Energy
VLO
$90.6B
$10.2M 0.53%
202,599
+144,645
+250% +$7.97M
OKE icon
17
Oneok
OKE
$58.7B
$9.95M 0.52%
146,204
+101,809
+229% +$6.44M
KMI icon
18
Kinder Morgan
KMI
$72.9B
$9.64M 0.5%
265,984
+10,972
+4% +$370K
HAR
19
DELISTED
Harman International Industries
HAR
$9.19M 0.48%
+85,499
New +$9.08M
PFE icon
20
Pfizer
PFE
$143B
$8.95M 0.47%
+317,723
New +$9.06M
MON
21
DELISTED
Monsanto Co
MON
$8.8M 0.46%
70,584
+38,198
+118% +$4.47M
NTAP icon
22
NetApp
NTAP
$32.3B
$8.72M 0.45%
238,774
-54,549
-19% -$1.95M
CF icon
23
CF Industries
CF
$19.5B
$8.66M 0.45%
+180,070
New +$8.81M
XOM icon
24
ExxonMobil
XOM
$650B
$8.57M 0.45%
+85,174
New +$8.59M
VIPS icon
25
Vipshop
VIPS
$6.92B
$8.49M 0.44%
452,250
-128,180
-22% -$2.05M

Similar funds

A.R.T. Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, A.R.T. Advisors held 1,808 positions worth $1.92B, up 1.7% from $1.89B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

A.R.T. Advisors's Q2 2014 filing shows 515 new, 353 increased, 371 reduced and 534 closed positions. Its largest new stake was QUESTCOR PHARMA INC: 202,374 shares worth $18.7M. The largest sale was Netflix, an estimated $18.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • A.R.T. Advisors's largest Q2 2014 buy was QUESTCOR PHARMA INC: 202,374 shares worth $18.7M.
  • A.R.T. Advisors added most to Ulta Beauty in Q2 2014, an estimated $9.55M increase.
  • A.R.T. Advisors's biggest Q2 2014 reduction was Anadarko Petroleum, cutting an estimated $8.4M.
  • A.R.T. Advisors fully exited Netflix in Q2 2014, selling an estimated $18.5M.
  • A.R.T. Advisors's ten largest holdings make up 8.4% of its $1.92B portfolio in Q2 2014.
  • A.R.T. Advisors opened 515 new positions and closed 534 in Q2 2014.
  • A.R.T. Advisors's portfolio value rose 1.7% quarter-over-quarter to $1.92B.

Based on A.R.T. Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.